Submission of Matters to a Vote of Security

On June 23, 2022, Aspira Women’s Health Inc. (the “Company”) held its 2022 annual meeting of stockholders (the “Annual Meeting”).  As of the close of business on the record date for the Annual Meeting, there were 112,209,064 shares of the Company’s common stock, par value $0.001 per share, issued and outstanding and entitled to vote. There were 86,593,211 shares present in person or by proxy at the Annual Meeting, constituting a quorum. The final voting results were as follows: 

Proposal 1:  Election of Directors 

Stockholders elected each of the Company’s seven nominees for director for a one-year term expiring at the Company’s 2023 annual meeting of stockholders and until their successors are elected and qualified, as set forth below:



 

 

 

 

NOMINEE

FOR

AGAINST

ABSTENTIONS

BROKER NON-VOTES

Robert Auerbach, M.D.

61,776,285

113,239

2,520,058

22,183,629

Celeste R. Fralick, Ph.D.

61,785,705

103,903

2,519,974

22,183,629

Veronica G.H. Jordan, Ph.D.

60,062,953

1,998,276

2,348,353

22,183,629

James T. LaFrance

56,752,970

4,959,507

2,697,105

22,183,629

Valerie B. Palmieri

60,944,593

772,586

2,692,403

22,183,629

Nicole Sandford

61,756,879

301,500

2,351,203

22,183,629

Ruby Sharma

61,439,394

104,214

2,865,974

22,183,629



Proposal 2:  Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 29, 2022, as set forth below:



 

 

 

FOR

AGAINST

ABSTENTIONS

BROKER NON-VOTES

56,797,736

4,773,973

2,837,873

22,183,629



Proposal

3: Proposal 3 was removed from stockholder consideration by the Board of Directors.

Proposal 4:  Ratification of the Selection of the Company’s Independent Registered Public Accounting Firm

The Company’s stockholders ratified the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022, as set forth below:



6,476,513

24,155

9



 

 

 

FOR

AGAINST

ABSTENTIONS

BROKER NON-VOTES

86,476,513

24,155

92,543

0





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ASPIRA WOMEN’S HEALTH INC.

Date: June 27, 2022

By:

/s/ Robert Beechey

Robert Beechey

Chief Financial Officer





makes a similar move, sign up!

Other recent filings from the company include the following:

Vermillion's President and CEO was just granted 5,000 options - Sept. 1, 2022
Vermillion's General Counsel & Secretary just picked up 26,667 shares - Aug. 30, 2022
Vermillion director just picked up 13,332 shares - Aug. 29, 2022
Vermillion's President & CEO just picked up 66,667 shares - Aug. 29, 2022
Jack W. Schuler Living Trust just provided an update on activist position in Vermillion - Aug. 29, 2022

Auto Refresh

Feedback